Overview

This trial is active, not recruiting.

Conditions tuberculosis, lung cancer
Sponsor Taipei Medical University WanFang Hospital
Start date July 2010
End date June 2011
Trial size 40 participants
Trial identifier NCT01322685, 99042

Summary

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Arm
Tuberculosis or lung cancer group

Eligibility Criteria

Male or female participants from 17 years up to 90 years old.

Inclusion Criteria: - Health group: between 17 to 90 years old - Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old Exclusion Criteria: - Women subjects are before or after the period within two days

Additional Information

Official title Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
Principal investigator Kuo-Sheng Hung
Trial information was received from ClinicalTrials.gov and was last updated in March 2011.
Information provided to ClinicalTrials.gov by Taipei Medical University WanFang Hospital.